Lab Automation Market

Lab Automation Market Size, Market Forecast and Outlook By FMI

The lab automation market is expected to expand from USD 2.7 billion in 2026 to USD 6.9 billion by 2036. The market is anticipated to register a 9.7% CAGR during the forecast period. Biochemistry devices and molecular devices are likely to lead device demand, while life sciences research and drug discovery are projected to remain core application areas in 2026.

Summary of the Lab Automation Market

• Demand and Growth Drivers
  • High-throughput testing needs are likely to support wider use of automated lab systems.
  • Personalized medicine growth is set to increase demand for faster biomarker analysis.
  • Clinical labs are anticipated to use automation to reduce errors and turnaround time.
• Product and Segment View
  • Biochemistry devices are likely to gain demand through automated sample and reagent handling.
  • Molecular devices are expected to support growth in genomics and precision diagnostics.
  • Software tools are anticipated to improve scheduling and workflow control across automated labs.
• Geography and Competitive Outlook
  • North America is likely to retain strong demand through pharma R&D and clinical diagnostics.
  • Europe is expected to show steady growth through compliance-focused lab modernization.
  • Asia Pacific is anticipated to expand faster as biopharma and CRO activity rises.
• Analyst Opinion
  • Sabyasachi Ghosh, Associate Vice President for Healthcare at FMI, suggests, “The lab automation market is moving toward connected, high-throughput laboratory environments that improve accuracy and research speed. Companies with reliable robotics, AI-based analytics, and flexible workflow software are likely to gain advantage as labs modernize research and diagnostics operations.”
• Lab Automation Market Value Analysis
  • The lab automation market is moving from manual workflows into automated research environments.
  • Demand is likely to strengthen as laboratories seek faster and more reproducible testing.
  • Platform value is expected to improve through robotic handling and AI-based data interpretation.
  • Investment is anticipated to rise around molecular automation and cloud-connected lab management systems.

Key Takeaways, Market Size, and Forecast

• The lab automation market was valued at USD 2.5 billion in 2025.
• The market is likely to stand at USD 2.7 billion in 2026.
• By 2036, the lab automation market is projected to total USD 6.9 billion.
• Lab automation demand is anticipated to expand at a 9.7% CAGR from 2026 to 2036.
• Biochemistry devices and molecular devices are likely to remain key device categories in 2026.
• Life sciences research and drug discovery are expected to stay major application areas.
• North America and Asia Pacific are likely to remain important growth regions through 2036.

 

Lab Automation Market Definition

The Lab Automation Market includes automated instruments, devices, software, and integrated systems used in pharmaceutical, clinical, and research laboratories for sample management, liquid handling, detection, analysis, and data management. Products range from standalone automated instruments to fully integrated laboratory workflow platforms.

Lab Automation Market Inclusions

Market scope covers all commercially traded lab automation products classified by component type (devices, software), application (life sciences research and development, drug discovery, diagnostics), end user (pharmaceutical companies, hospitals and diagnostic centers, educational institutions, contract research organizations, research institutes), and workflow type (sample management and preparation, liquid handling and dispensing, detection and analysis, data management LIMS). Revenue coverage spans 2026 to 2036.

Lab Automation Market Exclusions

The scope does not include general laboratory furniture and fixtures, manual laboratory instruments without automation features, or building management systems for laboratory facilities.

Lab Automation Market Research Methodology

• Primary Research: FMI analysts conducted interviews with industry participants, technology providers, procurement specialists, and end users across key markets.
• Desk Research: Combined data from industry associations, regulatory filings, manufacturer disclosures, and published technical standards.
• Market Sizing and Forecasting: Bottom up aggregation across segments and regions with top down validation against industry benchmarks.
• Data Validation: Cross checked quarterly against industry production data, procurement records, and manufacturer financial disclosures.

Why is the Lab Automation Market Growing?

• High throughput screening demand in pharmaceutical R and D is sustaining investment in automated liquid handling and detection platforms that support large compound library processing and lead optimization workflows.
• Clinical laboratory consolidation and testing volume growth are driving procurement of automated sample preparation and analysis systems that improve throughput while reducing labor dependency and error rates.

Demand for lab automation reflects the increasing complexity and volume of analytical work across pharmaceutical, clinical, and research settings. Drug discovery programs require screening of compound libraries that exceed manual processing capacity, while clinical laboratories face growing testing volumes driven by expanded diagnostic criteria, population health screening programs, and personalized medicine adoption. Automation addresses these pressures by increasing throughput, reducing variability, and enabling continuous operation of sample processing and analysis workflows.

The integration of laboratory information management systems with physical automation platforms is transforming procurement decisions. Buyers are increasingly evaluating automation solutions on the basis of software connectivity, data management capability, and compatibility with existing informatics infrastructure rather than instrument specifications alone. This shift favors vendors that offer complete workflow platforms with embedded data capture, audit trail functionality, and integration with enterprise laboratory systems.

Miniaturization trends in assay development are creating demand for automated platforms that can handle reduced sample and reagent volumes with high precision. Microplate based assays using 384 and 1536 well formats require liquid handling systems with nanoliter dispensing accuracy, acoustic dispensing capability, and integrated plate management. These requirements are expanding the addressable market for specialized automation instruments that support miniaturized high throughput workflows.

Market Segmentation Analysis

• Devices account for 65.0% of the component type segment, reflecting the capital intensive nature of laboratory automation procurement where physical instruments represent the primary investment category.
• Life Sciences Research and Development holds 38.0% of the application segment, supported by pharmaceutical pipeline expansion and growing investment in automated drug discovery platforms.

The Lab Automation Market is segmented by component type, application, end user, and workflow type. Devices dominate component demand, reflecting the capital equipment nature of laboratory automation. Life Sciences Research and Development leads the application segment as pharmaceutical and biotech companies invest in automated discovery and screening platforms.

Insights into the Devices Component Segment

In 2026, Devices is expected to represent 65.0% of the component type segment. This category includes liquid handling robots, microplate readers, automated sample preparation instruments, and integrated workstations. Procurement is concentrated in pharmaceutical companies, large clinical laboratories, and contract research organizations that require high throughput processing capability.

The shift toward modular and scalable device architectures is influencing procurement patterns, as laboratories seek automation platforms that can be configured for current workflows and expanded as testing requirements grow.

Insights into the Life Sciences Research and Development Application Segment

Life Sciences Research and Development accounts for 38.0% of the application segment in 2026. This category covers automation used in drug discovery, compound screening, assay development, and preclinical research workflows. Pharmaceutical and biotech companies are the primary buyers.

Growth in this segment reflects the expansion of pharmaceutical R and D pipelines, particularly in biologics and cell therapy development where automated cell culture, assay execution, and analytical characterization platforms are becoming standard laboratory infrastructure.

Lab Automation Market Drivers, Restraints, and Opportunities

• Pharmaceutical R and D investment and diagnostic testing volume growth are sustaining demand for automated laboratory platforms across discovery, development, and clinical applications.
• High instrument costs and integration complexity limit adoption among smaller laboratories and academic institutions with constrained capital budgets.
• AI integration with laboratory automation is creating new service categories including automated experiment design, predictive maintenance, and intelligent result interpretation.

The Lab Automation Market is shaped by pharmaceutical R and D investment, diagnostic testing volume growth, and technology integration trends. Growth is supported by throughput requirements and regulatory compliance mandates, while adoption barriers include high capital costs and system integration complexity.

Pharmaceutical R and D Pipeline Expansion

Demand is shaped by growing pharmaceutical R and D investment, particularly in biologics, cell therapy, and gene therapy programs that require automated cell culture, assay execution, and analytical characterization. The increasing size and complexity of compound libraries is sustaining procurement of high throughput screening platforms.

Capital Cost and Integration Barriers

Adoption is constrained by the high upfront cost of automated laboratory systems and the complexity of integrating new instruments with existing laboratory informatics infrastructure. Smaller laboratories and academic institutions face particular challenges in justifying automation investment against limited and competitive budget allocations.

AI Powered Laboratory Intelligence

Growth reflects the integration of artificial intelligence with physical automation platforms, enabling capabilities including automated experiment design, predictive maintenance scheduling, and intelligent result interpretation. These AI enabled features are becoming procurement criteria for advanced laboratory environments.

Analysis of Lab Automation Market By Key Countries

Country	CAGR
USA	10.3%
European Union	9.8%
South Korea	9.7%
Japan	9.6%
UK	9.4%

Source: FMI analysis based on primary research and proprietary forecasting model

• The USA leads with a 10.3% CAGR through 2036, driven by pharmaceutical R and D investment, clinical laboratory expansion, and early adoption of AI integrated automation platforms.
• The European Union at 9.8% reflects demand from centralized laboratory networks, pharmaceutical manufacturing automation, and government funded research infrastructure programs.
• South Korea (9.7%) and Japan (9.6%) are expanding on account of biotechnology industry growth, clinical laboratory modernization, and increasing investment in automated diagnostic platforms.

The global Lab Automation Market is projected to grow at a CAGR of 9.7% from 2026 to 2036. The analysis covers more than 30 countries, with the primary markets listed below.

Demand Outlook for Lab Automation Market in the United States

The USA is expected to grow at 10.3% through 2036. Growth is anchored in pharmaceutical R and D spending, clinical laboratory consolidation, and adoption of AI integrated automation platforms for drug discovery and diagnostic testing.

• Pharmaceutical pipeline expansion is sustaining investment in automated high throughput screening and compound management systems.
• Clinical laboratory consolidation is driving procurement of automated sample preparation and analysis platforms.
• AI integration with laboratory instruments is creating demand for intelligent automation solutions with predictive capabilities.

Future Outlook for Lab Automation Market in the European Union

The European Union is expected to grow at 9.8% through 2036. Demand is shaped by centralized laboratory network development, pharmaceutical manufacturing automation requirements, and government funded research infrastructure investment.

• Centralized diagnostic laboratory networks are driving procurement of high throughput automated testing platforms.
• Pharmaceutical manufacturing quality requirements are sustaining investment in automated in process testing and release testing systems.
• Government funded research programs are supporting automation adoption in academic and public research laboratories.

Opportunity Analysis of Lab Automation Market in South Korea

South Korea is expected to grow at 9.7% through 2036. Growth reflects biotechnology industry expansion, government investment in laboratory infrastructure, and increasing adoption of automated diagnostic platforms in clinical settings.

• Biotechnology sector growth is creating demand for automated cell culture and bioassay platforms.
• Government laboratory modernization programs are accelerating procurement of integrated automation systems.
• Clinical diagnostic volume growth is driving investment in automated sample processing and analysis equipment.

In-depth Analysis of Lab Automation Market in Japan

Japan is expected to grow at 9.6% through 2036. Demand reflects pharmaceutical industry investment in automated drug discovery platforms, clinical laboratory workforce constraints, and government support for life sciences research infrastructure.

• Pharmaceutical R and D investment is sustaining procurement of automated screening and analytical characterization systems.
• Laboratory workforce shortages are driving adoption of automated sample handling and processing solutions.
• Government life sciences research funding is supporting automation deployment in academic and institutional laboratories.

Sales Analysis of Lab Automation Market in the United Kingdom

The UK is expected to grow at 9.4% through 2036. Growth is supported by NHS laboratory consolidation, pharmaceutical industry investment, and university research infrastructure modernization programs.

• NHS laboratory network consolidation is driving procurement of standardized automated testing platforms.
• Pharmaceutical industry investment in biologics and cell therapy is creating demand for specialized automation solutions.
• University research infrastructure funding is supporting automation adoption across academic laboratory settings.

Competitive Landscape and Strategic Positioning

• Thermo Fisher Scientific leads through a comprehensive instrument portfolio spanning liquid handling, detection, and sample preparation with established pharmaceutical and clinical laboratory distribution networks.
• Beckman Coulter (Danaher), Siemens Healthineers, and Agilent Technologies maintain strong positions through specialized automation platforms and integrated workflow solutions for clinical and research applications.
• Emerging players are targeting niche segments including cloud connected laboratory automation, modular microfluidic platforms, and AI powered experiment management systems.

Thermo Fisher Scientific maintains a leading position through its broad laboratory automation portfolio covering liquid handling robots, microplate readers, automated sample preparation systems, and integrated laboratory workflow platforms. Beckman Coulter (Danaher) provides specialized clinical and research automation solutions.

Siemens Healthineers delivers diagnostic laboratory automation including pre analytical, analytical, and post analytical systems. PerkinElmer provides detection and imaging automation for life sciences research applications.

Agilent Technologies offers chromatography and spectroscopy automation solutions. Tecan Group and Hamilton Company specialize in liquid handling and laboratory robotics platforms serving pharmaceutical, clinical, and research customers.

Barriers to entry include the capital intensive nature of instrument development, established distribution relationships, regulatory approval requirements for clinical laboratory instruments, and the need for comprehensive service and support infrastructure. Strategic priorities include expanding AI and analytics integration, developing modular and scalable platform architectures, and building software connectivity capabilities.

Key Companies in the Lab Automation Market

Key global companies leading the lab automation market include:

• Thermo Fisher Scientific, Inc. (USA), Beckman Coulter (Danaher Corporation) (USA), Siemens Healthineers AG (Germany), PerkinElmer, Inc. (USA) maintain leadership positions through established market presence, broad product portfolios, and global service and distribution networks.
• Agilent Technologies, Inc. (USA), Tecan Group Ltd. (Switzerland), Hamilton Company (USA) have established regional strength through specialized capabilities and focused customer relationships.
• Labcyte Inc., Luminex Corporation, BioTek Instruments, Transcriptic (Strateos) are among the startups and emerging players gaining traction through specialized technology, niche applications, and focused innovation strategies.

Competitive Benchmarking: Lab Automation Market

Company	Instrument Portfolio Breadth	Software Integration	Pharma Customer Access	Geographic Coverage
Thermo Fisher Scientific	High	High	Strong	Global
Beckman Coulter (Danaher)	High	High	Strong	Global
Siemens Healthineers AG	High	High	Strong	Global
PerkinElmer, Inc.	Medium	High	Strong	Global
Agilent Technologies	High	High	Strong	Global
Tecan Group Ltd.	Medium	High	Moderate	Global
Hamilton Company	Medium	High	Moderate	Global
Labcyte Inc.	Low	Medium	Moderate	North America
BioTek Instruments	Medium	Medium	Moderate	Global
Opentrons	Low	Medium	Low	North America

Source: Future Market Insights competitive analysis, 2026.

Key Players in the Lab Automation Market

Major Global Players

• Thermo Fisher Scientific, Inc.
• Beckman Coulter (Danaher Corporation)
• Siemens Healthineers AG
• PerkinElmer, Inc.
• Agilent Technologies, Inc.
• Tecan Group Ltd.
• Hamilton Company

Emerging Players/Startups

• Labcyte Inc.
• Luminex Corporation
• BioTek Instruments
• Transcriptic (Strateos)
• Opentrons

Report Scope and Coverage

Metric	Value
Quantitative Units	USD 2.74 billion to USD 6.92 billion, at a CAGR of 9.7%
Market Definition	The Lab Automation Market includes automated instruments, devices, software, and integrated systems used in pharmaceutical, clinical, and research laboratories.
Regions Covered	North America, Latin America, Europe, East Asia, South Asia and Pacific, Middle East and Africa
Countries Covered	USA, UK, France, Germany, Italy, South Korea, Japan, China, India, 30 plus countries
Key Companies Profiled	Thermo Fisher Scientific, Inc., Beckman Coulter (Danaher Corporation), Siemens Healthineers AG, PerkinElmer, Inc., Agilent Technologies, Inc., Tecan Group Ltd., Hamilton Company, Labcyte Inc., BioTek Instruments, Opentrons
Forecast Period	2026 to 2036
Approach	Hybrid bottom up and top down methodology starting with verified transaction data, projecting adoption velocity across segments and regions.

Segmentation

Lab Automation Market Segmented by Component Type:

• Devices
  • Biochemistry Devices
  • Molecular Devices
  • Hematology Devices
  • Immunology Devices
  • Microbiology Devices
  • Others
• Software
  • Scheduling Software
  • Momentum Integration Software

Lab Automation Market Segmented by Application:

• Life Sciences Research and Development
• Drug Discovery
• Diagnostics

Lab Automation Market Segmented by End User:

• Pharmaceutical Companies
• Hospitals and Diagnostic Centers
• Educational Institutions
• Contract Research Organizations
• Research Institutes

Lab Automation Market Segmented by Workflow Type:

• Sample Management & Preparation
• Liquid Handling & Dispensing
• Detection & Analysis
• Data Management - LIMS
• Other

Lab Automation Market by Region:

• North America
  • USA
  • Canada
  • Mexico
• Latin America
  • Brazil
  • Chile
  • Rest of Latin America
• Western Europe
  • Germany
  • UK
  • Italy
  • Spain
  • France
  • Nordic
  • BENELUX
  • Rest of Western Europe
• Eastern Europe
  • Russia
  • Poland
  • Hungary
  • Balkan & Baltic
  • Rest of Eastern Europe
• East Asia
  • China
  • Japan
  • South Korea
• South Asia and Pacific
  • India
  • ASEAN
  • Australia & New Zealand
  • Rest of South Asia and Pacific
• Middle East & Africa
  • Kingdom of Saudi Arabia
  • Other GCC Countries
  • Turkiye
  • South Africa
  • Other African Union
  • Rest of Middle East & Africa

Research Sources and Bibliography

• 1. USA Food and Drug Administration. (2025). FDA Laboratory Quality Standards and Automation Guidance. FDA.
• 2. European Medicines Agency. (2024). EMA Good Manufacturing Practice Guidelines for Laboratory Operations. EMA.
• 3. International Society for Pharmaceutical Engineering. (2025). ISPE Baseline Guide: Laboratory Automation Systems. ISPE.
• 4. World Health Organization. (2025). WHO Laboratory Quality Management System Handbook. WHO.
• 5. National Institutes of Health. (2025). NIH Research Infrastructure Investment Report. NIH.

This bibliography is provided for reader reference. The full Future Market Insights report contains the complete reference list with publication dates, URLs, and supporting data for all cited works.

This Report Answers

• Estimating the market size and revenue projections from 2026 to 2036.
• Segmentation by component type, application, end user, and workflow type.
• Regional insights covering more than 30 markets.
• Analysis of automation technology platforms including devices and software.
• Competitive landscape assessment including instrument portfolio benchmarking.
• Identification of growth opportunities in AI integration, clinical automation, and modular platform development.
• Supply chain and instrument distribution evaluation.
• Data delivery in PDF and Excel formats.